CYLTEZO (adalimumab-adbm) Patient Assistance Program
Don’t let the cost of biologic therapy disrupt your treatment. We help eligible patients access Cyltezo (adalimumab-adbm) — an FDA-approved interchangeable biosimilar to Humira — for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Cyltezo (adalimumab-adbm) is FDA-approved to treat the same broad range of inflammatory conditions as the originator biologic adalimumab — including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. It carries an FDA interchangeability designation, allowing pharmacy-level substitution in many states.
- Without assistance, the average retail price of brand Cyltezo runs approximately $6,600–$7,900 per month for a typical every-other-week regimen. An unbranded version of the same biologic is available through a manufacturer-direct cash-pay program at approximately $550 per pack of two pens — substantially less than brand list price.
- Through AffordMyPrescriptions, qualifying patients can access Cyltezo for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Cyltezo itself is a biosimilar; several other biosimilars to Humira are also FDA-approved and may be available at different price points or through different assistance pathways
What is Cyltezo Prescription Assistance Program?
The Cyltezo Prescription Assistance Program is a manufacturer-sponsored initiative that provides Cyltezo at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for uninsured and underinsured individuals, as well as Medicare Part D beneficiaries who cannot afford biologic therapy.
Navigating the program on your own means dealing with eligibility verification, prescriber coordination, specialty pharmacy logistics, and renewal deadlines — all while managing a chronic immune-mediated condition that depends on consistent every-other-week dosing.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination, cold-chain delivery management, and annual re-certification — so you focus on your health, not paperwork.
Pharmacy Price Comparison
- Without assistance, Cyltezo costs roughly $6,600–$7,900 per month at retail pharmacies. Discount coupons offer some relief, but they don't come close to what a Patient Assistance Program provides — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$7,800.00 | Save ~$7,730/mo |
| CVS Pharmacy | ~$7,900.00 | Save ~$7,830/mo |
| Walmart | ~$7,200.00 | Save ~$7,130/mo |
| Costco | ~$6,900.00 | Save ~$6,830/mo |
| Kroger | ~$7,100.00 | Save ~$7,030/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Cyltezo Prescription Program ?
The Patient Assistance Program is free to apply for and provides Cyltezo at little or no medication cost if approved. But the process involves detailed applications, prescriber coordination, specialty pharmacy logistics, and ongoing renewal management — particularly important for a refrigerated biologic injectable. Our $69.95/month service covers full advocacy: applications, doctor coordination, cold-chain delivery management, refill management, and annual re-enrollment — so you focus on your health, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Abraxane:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $6,600–$7,900 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Abraxane assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Cyltezo Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Cyltezo:
Cyltezo (adalimumab-adbm) is an injectable biologic medicine in the tumor necrosis factor (TNF) inhibitor class. It is FDA-approved as an interchangeable biosimilar to Humira (adalimumab) and is used to treat a long list of immune-mediated conditions — rheumatoid arthritis, juvenile idiopathic arthritis (in patients 2 years and older), psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, moderate-to-severe plaque psoriasis, hidradenitis suppurativa, and certain forms of uveitis.
How It Works:
Chronic inflammatory diseases are often driven by an excess of TNF-alpha, a molecule that keeps the immune system over-activated. Cyltezo is an antibody-based biologic that binds to and neutralizes TNF-alpha, preventing it from interacting with immune cell receptors. This action reduces the underlying inflammation responsible for joint damage, skin plaques, and gut issues. As a biosimilar, it is clinically interchangeable with the original adalimumab.
Form and Use:
Cyltezo is administered via subcutaneous injection using either a prefilled syringe or a pen, with citrate-free formulations available in two concentrations. While a common maintenance dose is 40 mg every other week, specific loading schedules vary depending on the condition being treated, such as Crohn’s disease or psoriasis. The medication must be stored in a refrigerator and should never be allowed to freeze.
Generic Availability:
While traditional generics do not exist for biologics, Cyltezo serves as an FDA-approved interchangeable biosimilar to Humira. Several other biosimilars are also available, offering a more affordable path to treatment compared to the originator drug. For eligible patients, an unbranded version of the molecule is available through a cash-pay program, significantly reducing the annual cost of therapy.
Warnings:
The medication includes a for serious infections, such as tuberculosis and invasive fungal infections, as well as risks of malignancy like lymphoma. Patients must undergo screening for tuberculosis before beginning treatment to ensure safety. Frequent side effects include headaches, upper respiratory infections, and reactions at the injection site, and proper cooling must be maintained during travel.
FAQ (Frequently Asked Questions)
How Much Does Cyltezo Cost Without Insurance?
The average list price for a one-month supply (two pens or syringes at the common every-other-week dosing) is approximately $6,600–$7,900. Notably, an unbranded version of the same biologic (adalimumab-adbm) is available through a manufacturer-direct cash-pay program at approximately $550 per pack of two pens — far below the brand list price. Through AffordMyPrescriptions, qualifying patients receive Cyltezo at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Is Cyltezo The Same As Humira?
Cyltezo is an FDA-approved interchangeable biosimilar to Humira (adalimumab). That means the FDA has determined Cyltezo is therapeutically equivalent to Humira and may be substituted at the pharmacy in many states without a new prescription. Both products contain adalimumab and are used for the same broad range of inflammatory conditions.
Are There Cheaper Alternatives I Should Know About?
Yes. An unbranded version of adalimumab-adbm — the same molecule as brand Cyltezo — is available through a manufacturer-direct cash-pay program at approximately $550 per pack of two pens for eligible patients. Several other biosimilars to Humira are also FDA-approved and may be available at different price points. We mention this directly because if one of these alternatives would work for your situation, that may be a better path than paying for our advocacy on the brand.
How Should I Store Cyltezo?
Cyltezo is generally stored in the refrigerator (not frozen). When traveling, an insulated cooler pack helps keep the medication cold. The patient information leaflet that comes with your specific Cyltezo product (pen or syringe) explains exact storage and travel instructions, including any short-term room-temperature exceptions allowed.
What if my application is denied?
f your initial application is denied, we explore alternative savings paths on your behalf — including switching to the unbranded adalimumab-adbm cash-pay program (~$550/pack), the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the PAN Foundation or HealthWell Foundation, or asking your prescriber whether a different adalimumab biosimilar would work for your situation. If we cannot find a path to medication access, you will not be charged our service fee
Take Control of Your Medication Costs
If you are struggling with the high cost of Cyltezo, our team may be able to help you access assistance programs designed to make biologic therapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatmen
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.